SEC Company Response from AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818) (AYTU) — Jan 7, 2020

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)
Date: Jan. 7, 2020 · CIK: 0001385818 · Accession: 0001213900-20-000350

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-235548

Date

January 7, 2020

Author

Joshua Disbrow

Form

CORRESP

Company

AYTU BIOPHARMA, INC (AYTU) (CIK 0001385818)

Letter

Re: Aytu BioScience, Inc. (the “Company”)

January 7, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-3 (File No. 333-235548)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-3 (File No. 333-235548) be accelerated so that it will be declared effective at 4:00PM EST on Friday, January 10, 2020 or as soon thereafter as is practicable.

Very truly yours,
Aytu BioScience, Inc.

Show Raw Text

CORRESP
1
filename1.htm

January 7, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Re: Aytu BioScience, Inc. (the “Company”)

Registration Statement on Form S-3 (File No. 333-235548)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities
Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement on Form S-3
(File No. 333-235548) be accelerated so that it will be declared effective at 4:00PM EST on Friday, January 10, 2020 or as soon
thereafter as is practicable.

    Very truly yours,

    Aytu BioScience, Inc.

    By:
    /s/ Joshua Disbrow

    Name:
    Joshua Disbrow

    Title:
    Chief Executive Officer

SecProbe.io